2021 New Drugs in Oncology Seminar Planning Committee All Relationships Are Considered Compensated

2021 New Drugs in Oncology Seminar Planning Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Expert Testimony Travel, Other Relationship (OPTIONAL) (OPTIONAL) Open Ownership Interests Role Other Intellectual Accommodations, Uncompensated Payments Link Property Expenses Relationships Todd M. Bauer Tennessee Oncology AstraZeneca, Bayer, Bayer, Bristol-Myers Abbvie (Inst), Aileron Astellas Pharma, Blueprint Medicines, Squibb, Lilly Therapeutics (Inst), AstraZeneca, Celgene, Exelixis, Foundation Amgen (Inst), ARMO Clovis Oncology, EMD Medicine, Guardant BioSciences (Inst), Serono, Genentech, Lilly, Health, Ignyta (Inst), Loxo, Astellas Pharma (Inst), Merck, Novartis, Pfizer, Moderna Therapeutics AstraZeneca (Inst), Pharmacyclics, Sysmex (Inst), Pfizer (Inst), Pfizer Boehringer Ingelheim (Inst), Bristol-Myers Squibb (Inst), Calithera Biosciences (Inst), Clovis Oncology (Inst), Daiichi Sankyo (Inst), Deciphera (Inst), Five Prime Therapeutics (Inst), Foundation Medicine (Inst), Genentech/Roche (Inst), GlaxoSmithKline (Inst), Ignyta (Inst), Immunocore (Inst), Immunogen (Inst), Incyte (Inst), Jacobio (Inst), Janssen (Inst), Karyopharm Therapeutics (Inst), Kolltan Pharmaceuticals (Inst), Leap Therapeutics (Inst), Lilly (Inst), Loxo (Inst), MabVax (Inst), MedImmune (Inst), Medpacto (Inst), Merck (Inst), Merrimack (Inst), Millennium (Inst), Mirati Therapeutics (Inst), Moderna Therapeutics (Inst), Novartis (Inst), Onyx Noelle V. Frey Kite/Gilead, Novartis Novartis(Inst), Peleton (Inst), Pfizer Shivaani Kummar Arxeon (I), PathomIQ Bayer Bayer, Boehringer ADC Therapeutics (Inst), Bayer Ingelheim, Cadilla (I), Advenchen Laboratories Gilead, HarbourBiomed, (Inst), Amgen (Inst), Astex MedTree (I), Pharmaceuticals (Inst), Mundipharma, Seattle Bayer (Inst), Bristol-Myers Genetics, Shang Pharma, Squibb (Inst), Corvus Springworks Pharmaceuticals (Inst), Dynavax (Inst), Genome & Company (Inst), Incyte (Inst), Jounce Therapeutics (Inst), Loxo (Inst), Pfizer (Inst), Plexxikon (Inst), Seattle Genetics (Inst), Taiho Pharmaceutical (Inst)

Steven Lemery Patricia LoRusso Five Prime Therapeutics Abbvie, ABL Bio, Agenus, Genentech (Inst) Genentech Agios, Astellas Pharma, AstraZeneca, Black Diamond, Cybrexa Therapeutics, CytomX Therapeutic, EMD Serono, Five Prime Therapeutics, Genentech, Genmab, GlaxoSmithKline, Halozyme, ImmunoMet, IQvia, Kineta, Kyowa Kirin International, Macrogenics, Molecular Templates, Pfizer, QED Therapeutics, Roche/Genentech, Salarius Pharmaceuticals, Shattuck Labs, Silverback, SK Life Sciences, Sotio, ST Cub, Takeda, TRIGR, TYME, Zentalis Kathleen N. Moore Physician Education Abbvie, Aravive, Abbvie/Stemcentrx (Inst), Resource, Prime AstraZeneca (Inst), Eisai, Advaxis (Inst), Agenus Oncology, Research To Genentech/Roche, (Inst), AstraZeneca (Inst), Practice Immunogen, Merck, Bayer (Inst), Bristol-Myers Mersana (Inst), Myriad Squibb (Inst), Clovis Genetics, Pfizer/EMD Oncology (Inst), Forty Serono, Tesaro (Inst), Seven (Inst), Genentech Vavotar, VBL (Inst), Immunogen (Inst), Therapeutics Lilly (Inst), Lilly Foundation (Inst), Merck (Inst), Novartis Pharmaceuticals UK (Inst), Novogen (Inst), PTC Therapeutics (Inst), Regeneron (Inst), Stem CentRx (Inst), Takeda (Inst), Tesaro (Inst), Verastem (Inst)

Lillian L. Siu Treadwell Therapeutics (I) Agios (I) Arvinas, Amgen (Inst), Astellas AstraZeneca/MedImmune, Pharma (Inst), GlaxoSmithKline, Loxo, AstraZeneca (Inst), Avid Merck, Mirati (Inst), Bayer (Inst), Therapeutics, MorphoSys, Boehringer Ingelheim Navire, Oncorus, Rochel (Inst), Bristol-Myers Seattle Genetics, Squibb (Inst), Symphogen, Treadwell Genentech/Roche (Inst), Therapeutics, Voronoi GlaxoSmithKline (Inst), Intensity Therapeutics (Inst), Karyopharm Therapeutics (Inst), MedImmune (Inst), Merck (Inst), Mirati Therapeutics (Inst), Novartis (Inst), Pfizer (Inst), Shattuck Labs (Inst), Symphogen (Inst)

Timothy A. Yap Aduro Biotech, Almac, Artios (Inst), AstraZeneca AstraZeneca, Atrin (Inst), Bayer (Inst), Clovis Pharmaceuticals, Axiom Oncology Biotechnologies, Bayer, (Inst),Constellation Bristol-Myers Squibb, Pharmaceuticals (Inst), Calithera Biosciences, Cyteir (Inst), Eli Lilly (Inst), Clovis Oncology, Cybrexa, EMD Serono (Inst), F-Star EMD Serono, F-Star, (Inst), Forbius (Inst), Guidepoint Global, I-Mab, Genentech (Inst), Ignyta, Janssen, Merck, GlaxoSmithKline (Inst), Pfizer, Repare ImmuneSensor (Inst), Therapeutics, Roche, Ipsen (Inst), Jounce Rubius, Schrodinger, Therapeutics (Inst), Seattle Genetics, Varian Karyopharm Therapeutics Medical Systems, Zai Lab (Inst), Kyowa Hakko Kirin (Inst), Merck (Inst), Novartis (Inst), Pfizer (Inst), Regeneron (Inst), Repare Therapeutics (Inst), Ribon Therapeutics (Inst), Sanofi (Inst), Scholar Rock (Inst), Seattle Genetics (Inst), Tesaro (Inst), Vertex (Inst)